LAURA SINK: Open Payments
NPI 1629422654 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,364 in 58 payments from 17 companies in 2025. Trend: 2023 $1,638 · 2024 $1,252 · 2025 $1,364
Food & beverage: $1,174Education: $190
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $237 |
| Janssen Biotech, Inc. | 9 | $170 |
| Sumitomo Pharma America, Inc. | 7 | $150 |
| UROGEN PHARMA, INC. | 6 | $128 |
| PFIZER INC. | 5 | $113 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| ABBVIE INC. | 5 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $90 |
| ACCORD HEALTHCARE, INC. | 3 | $73 |
| Dendreon Pharmaceuticals LLC | 2 | $43 |
Products named: ERLEADA, XTANDI, JELMYTO, PLUVICTO, BOTOX, Nubeqa, ORGOVYX, Camcevi.
Industry payments across IN — which companies pay providers there.
